Mega Lifesciences PCL (BKK:MEGA)
29.50
-0.75 (-2.48%)
Apr 4, 2025, 4:37 PM ICT
Mega Lifesciences PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 26,374 | 28,990 | 35,093 | 40,760 | 44,029 | 31,169 | Upgrade
|
Market Cap Growth | -17.39% | -17.39% | -13.90% | -7.43% | 41.26% | 37.50% | Upgrade
|
Enterprise Value | 23,007 | 26,452 | 32,883 | 39,242 | 42,440 | 30,965 | Upgrade
|
Last Close Price | 30.25 | 32.45 | 37.76 | 42.24 | 44.00 | 30.40 | Upgrade
|
PE Ratio | 13.11 | 14.41 | 17.61 | 18.18 | 22.62 | 22.38 | Upgrade
|
Forward PE | 11.06 | 11.29 | 14.52 | 17.76 | 22.85 | 22.25 | Upgrade
|
PS Ratio | 1.71 | 1.88 | 2.23 | 2.59 | 3.11 | 2.47 | Upgrade
|
PB Ratio | 2.67 | 2.94 | 3.77 | 4.64 | 5.49 | 4.47 | Upgrade
|
P/TBV Ratio | 3.39 | 3.39 | 4.40 | 5.47 | 6.62 | 5.52 | Upgrade
|
P/FCF Ratio | 13.46 | 13.46 | 21.25 | 24.09 | 17.10 | 22.34 | Upgrade
|
P/OCF Ratio | 12.07 | 12.07 | 18.22 | 20.41 | 16.15 | 19.13 | Upgrade
|
PEG Ratio | 55.32 | 30.40 | 2.85 | 3.23 | 2.55 | 1.88 | Upgrade
|
EV/Sales Ratio | 1.50 | 1.72 | 2.09 | 2.50 | 3.00 | 2.46 | Upgrade
|
EV/EBITDA Ratio | 6.24 | 7.32 | 10.45 | 13.45 | 17.84 | 16.22 | Upgrade
|
EV/EBIT Ratio | 6.74 | 7.76 | 11.19 | 14.42 | 19.48 | 17.98 | Upgrade
|
EV/FCF Ratio | 10.68 | 12.28 | 19.91 | 23.19 | 16.48 | 22.20 | Upgrade
|
Debt / Equity Ratio | 0.05 | 0.05 | 0.03 | 0.05 | 0.04 | 0.09 | Upgrade
|
Debt / EBITDA Ratio | 0.13 | 0.13 | 0.08 | 0.14 | 0.15 | 0.33 | Upgrade
|
Debt / FCF Ratio | 0.23 | 0.23 | 0.15 | 0.25 | 0.14 | 0.46 | Upgrade
|
Asset Turnover | 1.09 | 1.09 | 1.09 | 1.13 | 1.14 | 1.14 | Upgrade
|
Inventory Turnover | 2.37 | 2.37 | 2.29 | 2.18 | 2.25 | 2.40 | Upgrade
|
Quick Ratio | 1.79 | 1.79 | 1.40 | 1.10 | 1.08 | 0.90 | Upgrade
|
Current Ratio | 2.61 | 2.61 | 2.26 | 1.91 | 1.92 | 1.79 | Upgrade
|
Return on Equity (ROE) | 20.99% | 20.99% | 22.04% | 26.66% | 25.87% | 21.11% | Upgrade
|
Return on Assets (ROA) | 15.05% | 15.05% | 12.77% | 12.19% | 10.97% | 9.75% | Upgrade
|
Return on Capital (ROIC) | 21.40% | 21.40% | 19.59% | 19.35% | 17.01% | 14.65% | Upgrade
|
Return on Capital Employed (ROCE) | 33.10% | 33.10% | 30.30% | 29.90% | 25.90% | 23.50% | Upgrade
|
Earnings Yield | 7.63% | 6.94% | 5.68% | 5.50% | 4.42% | 4.47% | Upgrade
|
FCF Yield | 8.17% | 7.43% | 4.71% | 4.15% | 5.85% | 4.48% | Upgrade
|
Dividend Yield | 5.29% | 4.93% | 4.24% | 3.79% | 3.14% | 2.96% | Upgrade
|
Payout Ratio | 69.30% | 69.30% | 72.23% | 62.71% | 47.41% | 48.12% | Upgrade
|
Buyback Yield / Dilution | - | - | - | - | -0.12% | Upgrade
| |
Total Shareholder Return | 5.29% | 4.93% | 4.24% | 3.79% | 3.14% | 2.84% | Upgrade
|
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.